National Bank of Canada’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Sell
62,905
-33,758
-35% -$8.41M 0.01% 594
2025
Q4
$23.3M Buy
96,663
+26,816
+38% +$6.86M 0.02% 480
2025
Q3
$19.1M Sell
69,847
-64,636
-48% -$17.7M 0.02% 511
2025
Q2
$34.7M Buy
134,483
+44,909
+50% +$10.7M 0.03% 391
2025
Q1
$20.1M Buy
89,574
+51,453
+135% +$12M 0.02% 517
2024
Q4
$8.72M Sell
38,121
-28,530
-43% -$6.87M 0.01% 815
2024
Q3
$16.3M Buy
66,651
+19,120
+40% +$4.27M 0.02% 543
2024
Q2
$8.88M Buy
47,531
+6,014
+14% +$1.22M 0.01% 593
2024
Q1
$8.88M Buy
41,517
+3,323
+9% +$609K 0.01% 652
2023
Q4
$6.56M Buy
38,194
+3,802
+11% +$584K 0.01% 672
2023
Q3
$5.01M Buy
34,392
+6,893
+25% +$1.25M 0.01% 795
2023
Q2
$5.91M Buy
27,499
+14,397
+110% +$3.21M 0.01% 673
2023
Q1
$2.87M Buy
13,102
+5,833
+80% +$1.27M 0.01% 748
2022
Q4
$1.51M Buy
7,269
+2,943
+68% +$647K ﹤0.01% 948
2022
Q3
$964K Sell
4,326
-236
-5% -$53.7K 0.01% 991
2022
Q2
$978K Sell
4,562
-3,042
-40% -$648K ﹤0.01% 1027
2022
Q1
$1.85M Buy
7,604
+3,328
+78% +$805K 0.01% 899
2021
Q4
$1.09M Buy
+4,276
New +$1.11M ﹤0.01% 1023

Other funds holding RMD

National Bank of Canada's RMD Position: Q1 2026 in Review

National Bank of Canada reduced its ResMed (RMD) stake by 35% in Q1 2026, selling an estimated $8.41M and leaving 62,905 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #594.

National Bank of Canada first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $34.7M in Q2 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • National Bank of Canada held 62,905 shares of ResMed worth $14.1M as of Q1 2026.
  • National Bank of Canada sold 33,758 ResMed shares in Q1 2026, an estimated $8.41M.
  • ResMed made up 0.01% of National Bank of Canada's portfolio in Q1 2026, its #594 holding.
  • National Bank of Canada first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's ResMed position peaked at $34.7M in Q2 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.